Literature DB >> 16735300

Optimal design of microarray immunoassays to compensate for kinetic limitations: theory and experiment.

Wlad Kusnezow1, Yana V Syagailo, Sven Rüffer, Nina Baudenstiel, Christoph Gauer, Jörg D Hoheisel, David Wild, Igor Goychuk.   

Abstract

In this report we examine the limitations of existing microarray immunoassays and investigate how best to optimize them using theoretical and experimental approaches. Derived from DNA technology, microarray immunoassays present a major technological challenge with much greater physicochemical complexity. A key physicochemical limitation of the current generation of microarray immunoassays is a strong dependence of antibody microspot kinetics on the mass flux to the spot as was reported by us previously. In this report we analyze, theoretically and experimentally, the effects of microarray design parameters (incubation vessel geometry, incubation time, stirring, spot size, antibody-binding site density, etc.) on microspot reaction kinetics and sensitivity. Using a two-compartment model, the quantitative descriptors of the microspot reaction were determined for different incubation and microarray design conditions. This analysis revealed profound mass transport limitations in the observed kinetics, which may be slowed down as much as hundreds of times compared with the solution kinetics. The data obtained were considered with relevance to microspot assay diffusional and adsorptive processes, enabling us to validate some of the underlying principles of the antibody microspot reaction mechanism and provide guidelines for optimal microspot immunoassay design. For an assay optimized to maximize the reaction velocity on a spot, we demonstrate sensitivities in the am and low fm ranges for a system containing a representative sample of antigen-antibody pairs. In addition, a separate panel of low abundance cytokines in blood plasma was detected with remarkably high signal-to-noise ratios.

Mesh:

Substances:

Year:  2006        PMID: 16735300     DOI: 10.1074/mcp.T500035-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  25 in total

Review 1.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

2.  Label-Free Impedance Biosensors: Opportunities and Challenges.

Authors:  Jonathan S Daniels; Nader Pourmand
Journal:  Electroanalysis       Date:  2007-05-16       Impact factor: 3.223

3.  Fast Immunoassay for Microfluidic Western Blotting by Direct Deposition of Reagents onto Capture Membrane.

Authors:  Natalie E Arvin; Mohamed Dawod; Don T Lamb; Jon P Anderson; Michael D Furtaw; Robert T Kennedy
Journal:  Anal Methods       Date:  2020-03-04       Impact factor: 2.896

4.  Photonic Crystal Surfaces as a General Purpose Platform for Label-Free and Fluorescent Assays.

Authors:  Brian T Cunningham
Journal:  JALA Charlottesv Va       Date:  2010-04-01

5.  Microarray-integrated optoelectrofluidic immunoassay system.

Authors:  Dongsik Han; Je-Kyun Park
Journal:  Biomicrofluidics       Date:  2016-05-12       Impact factor: 2.800

6.  Evaluation of surface chemistries for antibody microarrays.

Authors:  Shannon L Seurynck-Servoss; Amanda M White; Cheryl L Baird; Karin D Rodland; Richard C Zangar
Journal:  Anal Biochem       Date:  2007-07-25       Impact factor: 3.365

7.  Two-stage capture employing active transport enables sensitive and fast biosensors.

Authors:  Parag Katira; Henry Hess
Journal:  Nano Lett       Date:  2010-02-10       Impact factor: 11.189

8.  Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.

Authors:  Christoph Schröder; Anette Jacob; Sarah Tonack; Tomasz P Radon; Martin Sill; Manuela Zucknick; Sven Rüffer; Eithne Costello; John P Neoptolemos; Tatjana Crnogorac-Jurcevic; Andrea Bauer; Kurt Fellenberg; Jörg D Hoheisel
Journal:  Mol Cell Proteomics       Date:  2010-02-16       Impact factor: 5.911

9.  Oncoproteomic profiling with antibody microarrays.

Authors:  Mohamed Ss Alhamdani; Christoph Schröder; Jörg D Hoheisel
Journal:  Genome Med       Date:  2009-07-06       Impact factor: 11.117

10.  Mass-transport limitations in spot-based microarrays.

Authors:  Ming Zhao; Xuefeng Wang; David Nolte
Journal:  Biomed Opt Express       Date:  2010-09-20       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.